CRON
CRON
NASDAQ · Pharmaceuticals

Cronos Group Inc

$3.35
-0.02 (-0.59%)
As of Sep 20, 10:12 PM ET ·
Financial Highlights (FY 2026)
Revenue
207.23M
Net Income
-13,334,668
Gross Margin
43.3%
Profit Margin
-6.4%
Rev Growth
+16.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.3% 43.3% 54.9% 54.9%
Operating Margin -11.9% -10.7% 14.6% 14.7%
Profit Margin -6.4% -6.1% 12.8% 14.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 207.23M 177.36M 608.59M 622.30M
Gross Profit 89.65M 76.73M 334.31M 341.84M
Operating Income -24,598,131 -18,947,550 88.72M 91.23M
Net Income -13,334,668 -10,271,483 77.66M 87.35M
Gross Margin 43.3% 43.3% 54.9% 54.9%
Operating Margin -11.9% -10.7% 14.6% 14.7%
Profit Margin -6.4% -6.1% 12.8% 14.0%
Rev Growth +16.8% +16.8% +15.9% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 544.31M 499.08M
Total Equity 682.78M 653.80M
D/E Ratio 0.80 0.76
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -21,573,975 -17,541,318 120.12M 125.66M
Free Cash Flow 67.66M 69.93M